Linfeng Wu
Impact in
- Spectroscopy top 2%
- Advanced Proteomics Techniques and Applications
- Mass Spectrometry Techniques and Applications
- Molecular Biology top 5%
- Metabolomics and Mass Spectrometry Studies
- RNA Research and Splicing
- Genomics and Chromatin Dynamics
- RNA modifications and cancer
- RNA and protein synthesis mechanisms
- Ubiquitin and proteasome pathways
Papers in
-
- Ubiquitin and proteasome pathways 3
- RNA Research and Splicing 3
- RNA modifications and cancer 3
- Surgery 10
- Co-authors
- Sun‐Il Hwang (4 shared papers)David K. Han (3 shared papers)Deborah H. Lundgren (4 shared papers)Viveka Mayya (5 shared papers)M Snyder (5 shared papers)Karim Rezaul (4 shared papers)Jimmy K. Eng (3 shared papers)Dan Xie (2 shared papers)
- Journals
- PLoS ONE (3 papers)Molecular & Cellular Proteomics (3 papers)Frontiers in Oncology (2 papers)Frontiers in Endocrinology (2 papers)Annals of Oncology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Linfeng Wu
75 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 148
- Spectroscopy 510
- Molecular Biology 1.4k
- Cancer Research 166
- Immunology 202
- Cell Biology 145
Countries citing papers authored by Linfeng Wu
This map shows the geographic impact of Linfeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linfeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linfeng Wu more than expected).
Fields of papers citing papers by Linfeng Wu
This network shows the impact of papers produced by Linfeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linfeng Wu. The network helps show where Linfeng Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Linfeng Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 345 | |
| 2 | 2009 | 328 | |
| 3 | 2013 | 287 | |
| 4 | 2010 | 147 | |
| 5 | 2013 | 136 | |
| 6 | 2006 | 115 | |
| 7 | 2013 | 110 | |
| 8 | 2006 | 108 | |
| 9 | 2004 | 104 | |
| 10 | 2006 | 82 | |
| 11 | 2011 | 70 | |
| 12 | 2018 | 43 | |
| 13 | 2019 | 39 | |
| 14 | 2007 | 30 | |
| 15 | 2012 | 30 | |
| 16 | MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma. | 2017 | 28 |
| 17 | 2022 | 27 | |
| 18 | 2017 | 25 | |
| 19 | 2022 | 20 | |
| 20 | 2010 | 14 |
About Linfeng Wu
Linfeng Wu is a scholar working on Molecular Biology, Surgery, Oncology, Spectroscopy and Pulmonary and Respiratory Medicine, having authored 87 papers that have together received 2.4k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (7 papers), Mass Spectrometry Techniques and Applications (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Ubiquitin and proteasome pathways (3 papers), RNA Research and Splicing (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), RNA modifications and cancer (3 papers) and Machine Fault Diagnosis Techniques (3 papers). The work is most often cited by research in Spectroscopy (510 citations), Molecular Biology (1.4k citations), Cancer Research (166 citations), Immunology (202 citations) and Cell Biology (145 citations). Linfeng Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Sun‐Il Hwang, David K. Han, Deborah H. Lundgren, Viveka Mayya, M Snyder, Karim Rezaul, Jimmy K. Eng, Dan Xie, David K. Han and Vladimir Rodionov. Their work appears in journals such as PLoS ONE, Molecular & Cellular Proteomics, Frontiers in Oncology, Frontiers in Endocrinology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.